Excellent 11min talk: #ProstateCancer Initial Staging and Evaluation of Recurrent Disease with PSMA-Targeted PET by Johns Hopkins Radiology @HopkinsNucs colleague Dr. Steven Rowe: youtube.com/watch?v=0qfBC9… e.g. change in #RT plan on the basis of #PSMA #PET scan findings.

We are proud to introduce Dr. Sanjay Jain, Dr. Alvaro A. Ordóñez and Dr. Filipa Mota of Jain Lab @ Hopkins & Johns Hopkins Medicine. This team is a finalist in the #IDeaIncubator2021 competition, happening LIVE tonight during #IDWeek2021 festivities! Register now: bit.ly/3DwBOgQ

Tonight we are joined by @SaraSheikhbahai, liljasol, as well as our #AJRChat moderators Cynthia Czawlytko, MD & Christine Boone, MD, PhD. Who else is joining us?

Need something long to read? Review on molecular imaging in oncology from @HopkinsNucs and Martin Pomper, MD PhD. Lesson: journals need to give us word count limits. #molecularimaging #PSMA Rudi ASCO Ali Salavati, MD, MPH liljasol pubmed.ncbi.nlm.nih.gov/34902160/

For the cardiac imaging fans here 😉

An overview of imaging #prostatecancer with #pylarify #PSMA. Watch this space for future efforts. Rudi Michael Gorin, M.D. pubmed.ncbi.nlm.nih.gov/35030637/

Congrats Michael Gorin, M.D. and everyone! European Urology #renalmass #molecularimaging #mpMRI

hindawi.com/journals/moi/2… Proud of the team behind this. Rare imaging trial in which we found important clinical information and made a fundamental discovery. #PCF funded. #PSMA PCF Science Rudi Michael Gorin, M.D. Ali Salavati, MD, MPH Hopkins Med News

What can reporting and data systems (RADS) do for you? Quite a bit, if clinically useful and validated. Check out latest from Rudi and his team. pubmed.ncbi.nlm.nih.gov/35233654/ #RADS #molecularimaging

Moe Sadaghiani liljasol As usual, great work from Moe Sadaghiani. Even when he is gearing up for the core exam, he is still productive!

Nice publication from Rudi and team. CXCR4 imaging agents are promising for multiple myeloma and other cancers. #molecularimaging pubmed.ncbi.nlm.nih.gov/35312939/

Had the privilege to share the stage with Rudi and liljasol today at #AACR to discuss radioligand therapy for various cancers. Some technical glitches, but it was a well-attended and highly educational session. #RLT is here as a pillar of modern cancer therapy.

Targeting CXCR4: Another promising theranostic approach. ow.ly/ovOx50JJQNa #PersonalizedMedicine #NuclearMedicine #Lymphoma

How effective and safe is prolonged ¹⁷⁷Lu-PSMA treatment? ow.ly/K1N150K2ry5 #PrecisionOncology #NuclearMedicine #ProstateCancer

Phantom studies for scanner calibration are essential prior to in-vivo examinations: hindawi.com/journals/moi/2… Now everything set-up to perform inflammatory-targeted scans within SFB1525 Cardio-Immune Interfaces!

Looking for more information on 18F-labeled #PSMA #PET radio tracers? Check out our latest review. pubmed.ncbi.nlm.nih.gov/36229102/ #molecularimaging liljasol Rudi Michael Gorin, M.D.

CXCR4 for targeted imaging…now on to CXCR4 targeted therapy? ow.ly/AkPb50LwM9m #MedicalImaging #PETScan #Cancer

#AI for #breastcancer lesion detection. Jeff Leal is one of the smartest guys I know and he did a phenomenal job on this project. liljasol pubmed.ncbi.nlm.nih.gov/36457510/

Excellent work by Dr. Kevin Leung. pubmed.ncbi.nlm.nih.gov/36580220/ Working towards lesion-level characterization of findings on #PSMA #PET #RADS Michael Gorin, M.D. @pienta_brady

Check out our newest publication on #PSMA #PET with a novel radiotracer. pubmed.ncbi.nlm.nih.gov/36857019/ Written by the incomparable @SaraSheikhbahai. Rudi liljasol Michael Gorin, M.D.